Showing results (11-20 of 519) with videos related to
Sort By:
Pageof 52
Current Drug Safety|June 2, 2018
Risk and Benefit Profile of Dulaglutide in Established Therapeutic IndicationAakriti Garg, Anoop KumarBioinformatics (Oxford, England)|April 25, 2009
Augmented training of hidden Markov models to recognize remote homologs via simulated evolutionAnoop Kumar, Lenore CowenCurrent Neuropharmacology|August 20, 2020
Risks Associated with Vortioxetine in the Established Therapeutic IndicationAkansha Verma, Anoop KumarCurrent Drug Safety|February 28, 2023
Identification of Signal of Clindamycin Associated Renal Failure Acute: A Disproportionality AnalysisFaiza Javed, Anoop KumarEnvironmental Science and Pollution Research International|September 7, 2021
Abscisic acid and aloe-emodin against NS2B-NS3A protease of Japanese encephalitis virusSaiPriyanka Bhimaneni, Anoop KumarCritical Reviews in Oncology/Hematology|May 29, 2024
Safety of immune checkpoint inhibitors: An updated comprehensive disproportionality analysis and meta-analysisSimran Tyagi, Anoop KumarCNS & Neurological Disorders Drug Targets|March 4, 2020
Risk Analysis of Lurasidone in Patients with Schizophrenia and Bipolar DepressionHarika Modugula, Anoop KumarCurrent Research in Pharmacology and Drug Discovery|December 15, 2021
Screening of phytoconstituents of Andrographis paniculata against various targets of Japanese encephalitis virus: An in-silico and in-vitro target-based approachShailesh Bhosale, Anoop KumarActa Neurologica Scandinavica|August 27, 2022
Identification of novel signal of clobazam-associated drug reaction with eosinophilia and systemic symptoms syndrome: A disproportionality analysisAkash Sharma, Anoop KumarChemical Research in Toxicology|February 6, 2010
New biomarkers for monitoring the levels of isothiocyanates in humansAnoop Kumar, Gabriele SabbioniPageof 52